Erythropoietin as candidate for supportive treatment of severe COVID-19

2020 | journal article. A publication with affiliation to the University of Göttingen.

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Erythropoietin as candidate for supportive treatment of severe COVID-19​
Ehrenreich, H. ; Weissenborn, K.; Begemann, M. ; Busch, M.; Vieta, E. & Miskowiak, K. W.​ (2020) 
Molecular Medicine, 26(1).​ DOI: https://doi.org/10.1186/s10020-020-00186-y 

Copy

Further links

Documents & Media

document.pdf932.43 kBAdobe PDF

License

GRO License GRO License

Details

Authors
Ehrenreich, Hannelore ; Weissenborn, Karin; Begemann, Martin ; Busch, Markus; Vieta, Eduard; Miskowiak, Kamilla W.
Issue Date
2020
Journal
Molecular Medicine 
ISSN
1076-1551
eISSN
1528-3658
Language
English

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media